Market research on the consumer health industry. Our reports feat...
Market research on the consumer health industry. Our reports feature a wealth of standardised and cross-comparable statistics including total market sizes, market share and share data, distribution and industry trends.
Gastrointestinal disorders such as gastroesophageal reflux disease (GERD), peptic ulcers, and gastritis are relatively common in the United Arab Emirates. Digestive remedies such as proton pump inhibitors are effective in treating these conditions by…
One factor that spurred growth in sales of OTC digestive remedies during 2023 was the return to pre-pandemic lifestyles, with the accelerating pace of life in Philippine cities encouraging consumers to eat fast food and convenience food more often,…
In terms of retail current value sales, digestive remedies is projected to record healthy growth in 2023. This is mainly driven by average retail current unit price growth. In 2022, the growth in average unit prices was still relatively low, although…
Digestive remedies received a fillip in 2022 as international travel continued to return to pre-Coronavirus (COVID-19) pandemic levels. Despite the high inflation rate in the country and globally, Czech consumers and their counterparts in other…
Digestive remedies saw healthy growth in current value terms in 2023. As in the previous year, the return of busier, pre-pandemic lifestyles outside the home helped to trigger demand. This was in marked contrast to 2020 and 2021, when measures…
Consumption of digestive remedies in Taiwan has picked up in 2023, with most categories set to register stronger volume growth or lower rates of decline than in 2022. This is mainly explained by the easing of the pandemic, in that people have become…
Digestive remedies reported much stronger value growth in 2023 as consumers started eating outside the home once more, with greater exposure to bacterial infections. Sales of diarrhoeal remedies have increased as a greater number of consumers deal…
Retail sales of digestive remedies suffered a decline in constant value terms in 2023, albeit at a slower rate than the previous year. Growth continued to be impacted by inflationary pressures, exacerbated by the ongoing war in Ukraine, which…
Digestive remedies is experiencing a mixed performance in 2023, following an upturn in demand for some products the previous year in line with greater mobility outside of the home as pandemic-related restrictions eased. IBS treatments, antacids,…
Due to changes in dietary habits during the pandemic, such as the increase in delivery food, demand for certain digestive remedies exploded, while home seclusion during this time, resulting in sedentary lifestyles, supported the surge in demand for…